Antifungal susceptibility testing in Candida, Aspergillus and Cryptococcus infections: are the MICs useful for clinicians?

Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America

Pappas, P. G., Kauffman, C. A., Andes, D. R., Clancy, C. J., Marr, K. A., Ostrosky-Zeichner, L., Reboli, A. C., Schuster, M. G., Vazquez, J. A., Walsh, T. J., et al. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ933 · Cited by 4,200 · see citing works

Clinical Practice Guidelines for the Management of Cryptococcal Disease: 2010 Update by the Infectious Diseases Society of America

Perfect, J. R., Dismukes, W. E., Dromer, F., Goldman, D. L., Graybill, J. R., Hamill, R. J., Harrison, T. S., Larsen, R. A., Lortholary, O., Nguyen, M.-H., et al. (2010) · Clinical Infectious Diseases · doi:10.1086/649858 · Cited by 2,660 · see citing works

Diagnosis and management of Aspergillus diseases: executive summary of the 2017 ESCMID-ECMM-ERS guideline

Ullmann, A. J., Aguado, J. M., Arikan-Akdagli, S., Denning, D. W., Groll, A. H., Lagrou, K., Lass-Flörl, C., Lewis, R. E., Munoz, P., Verweij, P. E., et al. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2018.01.002 · Cited by 1,556 · see citing works

Antifungal drug resistance: mechanisms, epidemiology, and consequences for treatment

Pfaller, M. A. (2012) · The American Journal of Medicine · doi:10.1016/j.amjmed.2011.11.001 · Cited by 903 · see citing works

Increasing Echinocandin Resistance in Candida glabrata: Clinical Failure Correlates With Presence of FKS Mutations and Elevated Minimum Inhibitory Concentrations

Alexander, B. D., Johnson, M. D., Pfeiffer, C. D., Jiménez-Ortigosa, C., Catania, J., Booker, R., Castanheira, M., Messer, S. A., Perlin, D. S., & Pfaller, M. A. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit136 · Cited by 778 · see citing works

Frequency and Evolution of Azole Resistance in <i>Aspergillus fumigatus</i> Associated with Treatment Failure1

Howard, S. J., Cerar, D., Anderson, M. J., Albarrag, A., Fisher, M. C., Pasqualotto, A. C., Laverdiere, M., Arendrup, M. C., Perlin, D. S., & Denning, D. W. (2009) · Emerging Infectious Diseases · doi:10.3201/eid1507.090043 · Cited by 750 · see citing works

Azole Resistance in <i>Aspergillus fumigatus</i> : Can We Retain the Clinical Use of Mold-Active Antifungal Azoles?

Verweij, P. E., Chowdhary, A., Melchers, W. J. G., & Meis, J. F. (2016) · Clinical Infectious Diseases · doi:10.1093/cid/civ885 · Cited by 561 · see citing works

ESCMID and ECMM joint clinical guidelines for the diagnosis and management of rare invasive yeast infections

Arendrup, M. C., Boekhout, T., Akova, M., Meis, J. F. G. M., Cornely, O. A., & Lortholary, O. (2013) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12360 · Cited by 533 · see citing works

Clinical Implications of Azole Resistance inAspergillus fumigatus, the Netherlands, 2007–2009

van der Linden, J. W. M., Snelders, E., Kampinga, G. A., Rijnders, B. J. A., Mattsson, E., Debets-Ossenkopp, Y. J., Kuijper, E. J., van Tiel, F. H., Melchers, W. J. G., & Verweij, P. E. (2011) · Emerging infectious diseases · doi:10.3201/eid1710.110226 · Cited by 445 · see citing works

Prospective Multicenter International Surveillance of Azole Resistance in<i>Aspergillus fumigatus</i>

van der Linden, J. W. M., Arendrup, M. C., Warris, A., Lagrou, K., Pelloux, H., Hauser, P. M., Chryssanthou, E., Mellado, E., Kidd, S. E., Tortorano, A. M., et al. (2015) · Emerging Infectious Diseases · doi:10.3201/eid2106.140717 · Cited by 371 · see citing works

Has antifungal susceptibility testing come of age

Rex, J. H., & Pfaller, M. A. (2002) · Clinical Infectious Diseases · doi:10.1086/342384 · Cited by 361 · see citing works

Aspergillosis due to Voriconazole Highly Resistant Aspergillus fumigatus and Recovery of Genetically Related Resistant Isolates From Domiciles

van der Linden, J. W. M., Camps, S. M. T., Kampinga, G. A., Arends, J. P. A., Debets-Ossenkopp, Y. J., Haas, P. J. A., Rijnders, B. J. A., Kuijper, E. J., van Tiel, F. H., Varga, J., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit320 · Cited by 342 · see citing works

Azole antifungal resistance in Aspergillus fumigatus: 2008 and 2009

Bueid, A. S., Howard, S. J., Moore, C. B., Richardson, M. D., Harrison, E., Bowyer, P., & Denning, D. W. (2010) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkq279 · Cited by 333 · see citing works

Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry study

Pagano, L., Caira, M., Candoni, A., Offidani, M., Martino, B., Specchia, G., Pastore, D., Stanzani, M., Cattaneo, C. M., Fanci, R., et al. (2009) · Haematologica · doi:10.3324/haematol.2009.012054 · Cited by 317 · see citing works

Voriconazole Resistance and Mortality in Invasive Aspergillosis: A Multicenter Retrospective Cohort Study

Lestrade, P. P. A., Bentvelsen, R. G., Schauwvlieghe, A. F. A. D., Schalekamp, S., van der Velden, W. J. F. M., Kuiper, E. J., van Paassen, J., van der Hoven, B., van der Lee, H. A., Melchers, W. J. G., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy859 · Cited by 310 · see citing works

A multicenter study of septic shock due to candidemia: Outcomes and predictors of mortality.

Bassetti, M., Righi, E., Ansaldi, F., Merelli, M., Cecilia, T., De Pascale, G., Diaz-Martin, A., Luzzati, R., Rosin, C., Lagunes, L., et al. (2014) · Intensive Care Medicine · doi:10.1007/s00134-014-3310-z · Cited by 284 · see citing works

Geographic Variations in Species Distribution and Echinocandin and Azole Antifungal Resistance Rates among Candida Bloodstream Infection Isolates: Report from the SENTRY Antimicrobial Surveillance Program (2008 to 2009)

Pfaller, M. A., Moet, G. J., Messer, S. A., Jones, R. N., & Castanheira, M. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01398-10 · Cited by 228 · see citing works

Breakthrough invasive candidiasis in patients on micafungin.

Pfeiffer, C. D., Garcia-Effron, G., Zaas, A. K., Perfect, J. R., Perlin, D. S., & Alexander, B. D. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.02390-09 · Cited by 196 · see citing works

Increased Antifungal Drug Resistance in Clinical Isolates of Cryptococcus neoformans in Uganda

Smith, K. D., Achan, B., Hullsiek, K. H., McDonald, T. R., Okagaki, L. H., Alhadab, A. A., Akampurira, A., Rhein, J., Meya, D. B., Boulware, D. R., et al. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01299-15 · Cited by 191 · see citing works

Emergence of azole-resistant invasive aspergillosis in HSCT recipients in Germany

Steinmann, J., Hamprecht, A. G., Vehreschild, M. J. G. T., Cornely, O. A., Buchheidt, D., Spieß, B., Koldehoff, M., Buer, J., Meis, J. F. G. M., & Rath, P. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku566 · Cited by 184 · see citing works

High Prevalence of Azole-Resistant Aspergillus fumigatus in Adults with Cystic Fibrosis Exposed to Itraconazole

Burgel, P., Baixench, M.-T., Amsellem, M., Audureau, É., Chapron, J., Kanaan, R., Honoré, I., Dupouy‐Camet, J., Dusser, D. J., Klaassen, C. H. W., et al. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.05077-11 · Cited by 176 · see citing works

FKS Mutant Candida glabrata: Risk Factors and Outcomes in Patients With Candidemia

Beyda, N. D., John, J., Kilic, A., Alam, M. J., Lasco, T. M., & Garey, K. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu407 · Cited by 174 · see citing works

Correlation of Fluconazole MICs with Clinical Outcome in Cryptococcal Infection

Aller, A. I., Martín‐Mazuelos, E., Lozano, F., Gómez-Mateos, J. M., Steele‐Moore, L., Holloway, W. J., Gutiérrez, M. J., Recio, F., & Espinel-Ingroff, A. V. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.6.1544-1548.2000 · Cited by 171 · see citing works

The Presence of an <i>FKS</i> Mutation Rather than MIC Is an Independent Risk Factor for Failure of Echinocandin Therapy among Patients with Invasive Candidiasis Due to Candida glabrata

Shields, R. K., Nguyen, M. H., Press, E. G., Kwa, A. L., Cheng, S., Du, C., & Clancy, C. J. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00027-12 · Cited by 171 · see citing works

Association of fluconazole pharmacodynamics with mortality in patients with candidemia

Baddley, J. W., Patel, M., Bhavnani, S. M., Moser, S. A., & Andes, D. R. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00116-08 · Cited by 162 · see citing works

Association of Fluconazole Area under the Concentration-Time Curve/MIC and Dose/MIC Ratios with Mortality in Nonneutropenic Patients with Candidemia

Pai, M. P., Turpin, R. S., & Garey, K. W. (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00474-06 · Cited by 160 · see citing works

Triazole Resistance in Aspergillus Species: An Emerging Problem

Garcia‐Rubio, R., Cuenca‐Estrella, M., & Mellado, E. (2017) · Drugs · doi:10.1007/s40265-017-0714-4 · Cited by 155 · see citing works

Drug-Resistant<i>Candida glabrata</i>Infection in Cancer Patients

Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2014) · Emerging Infectious Diseases · doi:10.3201/eid2011.140685 · Cited by 152 · see citing works

Caspofungin Susceptibility Testing of Isolates from Patients with Esophageal Candidiasis or Invasive Candidiasis: Relationship of MIC to Treatment Outcome

Kartsonis, N. A., Killar, J., Mixson, L. A., Hoe, C., Sable, C. A., Bartizal, K. F., & Motyl, M. R. (2005) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.49.9.3616-3623.2005 · Cited by 137 · see citing works

Correlation of the MIC and dose/MIC ratio of fluconazole to the therapeutic response of patients with mucosal candidiasis and candidemia

Rodríguez-Tudela, J. L., Almirante, B., Rodríguez-Pardo, D., Laguna, F., Donnelly, J. P., Mouton, J. W., Pahissa, A., & Cuenca-Estrella, M. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00296-07 · Cited by 137 · see citing works

Identification of Patients with Acute AIDS-Associated Cryptococcal Meningitis Who Can Be Effectively Treated with Fluconazole: The Role of Antifungal Susceptibility Testing

Witt, M. D., Lewis, R. J., Larsen, R. A., Milefchik, E. N., Leal, M. A. E., Haubrich, R., Richie, J., Edwards, J. E., & Ghannoum, M. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.2.322 · Cited by 136 · see citing works

Breakpoints for antifungal agents: An update from EUCAST focussing on echinocandins against Candida spp. and triazoles against Aspergillus spp.

Arendrup, M. C., Cuenca-Estrella, M., Lass-Flörl, C., & Hope, W. W. (2013) · Drug Resistance Updates · doi:10.1016/j.drup.2014.01.001 · Cited by 129 · see citing works

Molecular Identification and Antifungal Susceptibility of Yeast Isolates Causing Fungemia Collected in a Population-Based Study in Spain in 2010 and 2011

Guinea, J., Zaragoza, Ó., Escribano, P., Martín‐Mazuelos, E., Pemán, J., Sánchez, F., & Cuenca‐Estrella, M. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02155-13 · Cited by 129 · see citing works

High prevalence of triazole resistance in Aspergillus fumigatus, especially mediated by TR/L98H, in a French cohort of patients with cystic fibrosis

Morio, F., Aubin, G. G., Danner‐Boucher, I., Haloun, A., Sacchetto, É., Garcia‐Hermoso, D., Bretagne, S., Miegeville, M., & Pape, P. L. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks160 · Cited by 123 · see citing works

Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: A propensity score analysis

Fernández-Ruiz, M., Aguado, J. M., Almirante, B., Lora-Pablos, D., Padilla, B., Puig-Asensio, M., Montejo, M., García-Rodríguez, J., Pemán, J., Ruiz Pérez de Pipaón, M., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu158 · Cited by 122 · see citing works

Abdominal candidiasis is a hidden reservoir of echinocandin resistance

Shields, R. K., Nguyen, M. H., Press, E. G., & Clancy, C. J. (2014) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.04134-14 · Cited by 118 · see citing works

High prevalence of azole resistance inAspergillus fumigatusisolates from high-risk patients

Führen, J., Voskuil, W. S., Boel, C. H. E., Haas, P., Hagen, F., Meis, J. F. G. M., & Kusters, J. G. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv177 · Cited by 107 · see citing works

Results Obtained with Various Antifungal Susceptibility Testing Methods Do Not Predict Early Clinical Outcome in Patients with Cryptococcosis

Dannaoui, É., Abdul, M., Arpin, M., Michel-Nguyen, A., Piens, M. A., Favel, A., Lortholary, O., Dromer, F., & the French Cryptococcosis Study Group (2006) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01520-05 · Cited by 102 · see citing works

Antifungal stewardship in daily practice and health economic implications

Muñóz, P., Valerio, M., Vena, A., & Bouza, E. (2015) · Mycoses · doi:10.1111/myc.12329 · Cited by 101 · see citing works

Emerging aspergillosis by azole-resistant Aspergillus fumigatus at an intensive care unit in the Netherlands, 2010 to 2013

van Paassen, J., Russcher, A., Wingerden, A. W. M. I. V.-V., Verweij, P. E., & Kuijper, E. J. (2016) · Eurosurveillance · doi:10.2807/1560-7917.es.2016.21.30.30300 · Cited by 96 · see citing works

Nationwide Surveillance of Azole Resistance in Aspergillus Diseases

Vermeulen, E., Maertens, J. A., Bel, A. D., Nulens, E., Boelens, J., Surmont, I., Mertens, A., Boel, A., & Lagrou, K. (2015) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00233-15 · Cited by 95 · see citing works

Epidemiology of invasive aspergillosis and azole resistance in patients with acute leukaemia: the SEPIA Study

Koehler, P., Hamprecht, A., Bader, O., Bekeredjian-Ding, I., Buchheidt, D., Doelken, G., Elias, J., Haase, G., Hahn-Ast, C., Karthaus, M., et al. (2017) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2016.10.019 · Cited by 91 · see citing works

Prevalence of voriconazole-resistant invasive aspergillosis and its impact on mortality in haematology patients

Reséndiz-Sharpe, A., Mercier, T., Lestrade, P. P. A., van der Beek, M. T., Borne, P. A. V. D., Cornelissen, J. J., de Kort, E., Rijnders, B. J. A., Schauwvlieghe, A. F. A. D., Verweij, P. E., et al. (2019) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkz258 · Cited by 91 · see citing works

Multicenter Study of Method-Dependent Epidemiological Cutoff Values for Detection of Resistance in Candida spp. and Aspergillus spp. to Amphotericin B and Echinocandins for the Etest Agar Diffusion Method

Espinel‐Ingroff, A., Arendrup, M. C., Cantón, R., Córdoba, S. B., Dannaoui, É., García‐Rodríguez, J., González, G. M., Govender, N. P., Martín‐Mazuelos, E., Lackner, M., et al. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01792-16 · Cited by 90 · see citing works

Is Azole Resistance in Aspergillus fumigatus a Problem in Spain?

Escribano, P., Peláez, T., Muñóz, P., Bouza, E., & Guinea, J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02487-12 · Cited by 85 · see citing works

The ever-evolving landscape of candidaemia in patients with acute leukaemia: non-susceptibility to caspofungin and multidrug resistance are associated with increased mortality

Wang, E., Farmakiotis, D., Yang, D., McCue, D. A., Kantarjian, H. M., Kontoyiannis, D. P., & Mathisen, M. S. (2015) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkv087 · Cited by 82 · see citing works

Prevalence and molecular characterization of azole resistance in Aspergillus spp. isolates from German cystic fibrosis patients

Fischer, J., Koningsbruggen-Rietschel, S. V., Rietschel, E., Vehreschild, M. J. G. T., Wisplinghoff, H., Krönke, M., & Hamprecht, A. G. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku009 · Cited by 75 · see citing works

Method-Dependent Epidemiological Cutoff Values for Detection of Triazole Resistance in Candida and Aspergillus Species for the Sensititre YeastOne Colorimetric Broth and Etest Agar Diffusion Methods

Espinel‐Ingroff, A., Turnidge, J. D., Alastruey‐Izquierdo, A., Botterel, F., Cantón, R., Castro, C., Chen, Y., Chen, Y., Chryssanthou, E., Dannaoui, É., et al. (2018) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01651-18 · Cited by 74 · see citing works

Increasing trend of fluconazole-non-susceptible Cryptococcus neoformans in patients with invasive cryptococcosis: a 12-year longitudinal study

Chen, Y., Chang, T.-Y., Liu, J.-W., Chen, F., Chien, C., Lee, C., & Lu, C. (2015) · BMC Infectious Diseases · doi:10.1186/s12879-015-1023-8 · Cited by 71 · see citing works

Trends in Antifungal Drug Susceptibility of Cryptococcus neoformans Isolates Obtained through Population-Based Surveillance in South Africa in 2002-2003 and 2007-2008

Govender, N. P., Patel, J., Wyk, M. V., Chiller, T. M., Lockhart, S. R., & for the Group for Enteric, R. A. M. D. S. I. S. A. (.-S. (2011) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00048-11 · Cited by 68 · see citing works

Antifungal susceptibilities of Candida, Cryptococcus neoformans and Aspergillus fumigatus from the Asia and Western Pacific region: data from the SENTRY antifungal surveillance program (2010–2012)

Pfaller, M. A., Messer, S. A., Jones, R. N., & Castanheira, M. (2015) · The Journal of Antibiotics · doi:10.1038/ja.2015.29 · Cited by 64 · see citing works

In vitro susceptibility testing in fungi: a global perspective on a variety of methods

Lass‐Flörl, C., Perkhofer, S., & Mayr, A. (2009) · Mycoses · doi:10.1111/j.1439-0507.2009.01813.x · Cited by 58 · see citing works

Anidulafungin and Micafungin MIC Breakpoints Are Superior to That of Caspofungin for Identifying <i>FKS</i> Mutant Candida glabrata Strains and Echinocandin Resistance

Shields, R. K., Nguyen, M. H., Press, E. G., Updike, C. L., & Clancy, C. J. (2013) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01451-13 · Cited by 56 · see citing works

Prevalence and characterization of azole-resistant Aspergillus fumigatus in patients with cystic fibrosis: a prospective multicentre study in Germany

Seufert, R., Sedlacek, L., Kahl, B. C., Hogardt, M., Hamprecht, A. G., Haase, G., Gunzer, F., Haas, A., Grauling-Halama, S., MacKenzie, C. R., et al. (2018) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dky147 · Cited by 53 · see citing works

Fluconazole versus an echinocandin for Candida glabrata fungaemia: a retrospective cohort study

Eschenauer, G. A., Carver, P. L., Lin, S., Klinker, K. P., Chen, Y., Potoski, B. A., Shields, R. K., Clancy, C. J., Nguyen, M. H., & Lam, S. W. (2012) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dks482 · Cited by 49 · see citing works

Breakthrough candidaemia in the era of broad-spectrum antifungal therapies

Cuervo, G., Garcia-Vidal, C., Nucci, M., Puchades, F., Fernández-Ruiz, M., Obed, M., Manzur, A., Gudiol, C., Pemán, J., Aguado, J. M., et al. (2016) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.029 · Cited by 49 · see citing works

Risk factors for late recurrent candidaemia. A retrospective matched case–control study

Muñóz, P., Vena, A., Valerio, M., Álvarez-Uría, A., Guinea, J., Escribano, P., & Bouza, E. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.10.023 · Cited by 48 · see citing works

Azole Antifungal Resistance Today: Focus on Aspergillus

Bowyer, P., Moore, C. B., Rautemaa, R., Denning, D. W., & Richardson, M. D. (2011) · Current Infectious Disease Reports · doi:10.1007/s11908-011-0218-4 · Cited by 44 · see citing works

Prospective evaluation of azole resistance inAspergillus fumigatusclinical isolates in France: Table 1.

Choukri, F., Botterel, F., Sitterlé, E., Bassinet, L., Foulet, F., Guillot, J., Costa, J., Fauchet, N., & Dannaoui, É. (2015) · Medical Mycology · doi:10.1093/mmy/myv029 · Cited by 40 · see citing works

Impact of fluconazole susceptibility on the outcome of patients with candidaemia: data from a population-based surveillance

Fernández‐Ruiz, M., Guinea, J., Lora, D., Zaragoza, Ó., Puig‐Asensio, M., Almirante, B., Cuenca‐Estrella, M., Aguado, J. M., Padilla, B., Muñóz, P., et al. (2017) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.01.014 · Cited by 27 · see citing works

Differential association of fluconazole dose and dose/MIC ratio with mortality in patients with Candida albicans and non-albicans bloodstream infection

Brosh‐Nissimov, T., & Ben‐Ami, R. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.07.005 · Cited by 26 · see citing works

Propensity Score Analysis of the Role of Initial Antifungal Therapy in the Outcome of Candida glabrata Bloodstream Infections

Puig‐Asensio, M., Fernández‐Ruiz, M., Aguado, J. M., Merino, P., Lora, D., Guinea, J., Martín‐Dávila, P., Cuenca‐Estrella, M., & Almirante, B. (2016) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00195-16 · Cited by 26 · see citing works

Support for the EUCAST and revised CLSI fluconazole clinical breakpoints by Sensititre(R) YeastOne(R) for Candida albicans: a prospective observational cohort study

van Hal, S. J., Chen, S. C. A., Sorrell, T. C., Ellis, D. H., Slavin, M. A., & Marriott, D. (2014) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dku124 · Cited by 25 · see citing works

Impact of inappropriate antifungal therapy according to current susceptibility breakpoints on Candida bloodstream infection mortality, a retrospective analysis

González-Lara, M. F., Torres‐González, P., Cornejo‐Juárez, P., Velázquez-Acosta, C., Martínez‐Gamboa, A., Rangel‐Cordero, A., Bobadilla-del-Valle, M., Ostrosky‐Zeichner, L., Ponce‐de‐León, A., & Sifuentes‐Osornio, J. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2846-2 · Cited by 21 · see citing works

Fluconazole resistance is not a predictor of poor outcome in patients with cryptococcosis

Vena, A., Muñóz, P., Guinea, J., Escribano, P., Peláez, T., Valerio, M., Bonache, F., Gago, S., Álvarez‐Uría, A., & Bouza, E. (2018) · Mycoses · doi:10.1111/myc.12847 · Cited by 20 · see citing works

Response to therapy in patients with cryptococcosis and AIDS: Association with in vitro susceptibility to fluconazole

Agudelo, C. A., Muñoz, C., Ramírez, Á., Tobón, Á. M., de BEDOUT, C., Cano, L. E., & Restrepo, Á. (2014) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2014.07.006 · Cited by 16 · see citing works

Initial Treatment of Cancer Patients with Fluconazole-Susceptible Dose-Dependent Candida glabrata Fungemia: Better Outcome with an Echinocandin or Polyene Compared to an Azole?

Le, A., Farmakiotis, D., Tarrand, J. J., & Kontoyiannis, D. P. (2017) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00631-17 · Cited by 12 · see citing works

Triazole-resistant candidaemia following posaconazole exposure

Weiler, S., Lass‐Flörl, C., Auberger, J., Bellmann‐Weiler, R., Stein, M., Joannidis, M., & Bellmann, R. (2009) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2008.12.001 · Cited by 10 · see citing works

Drug-Resistant Fungi: An Emerging Challenge Threatening Our Limited Antifungal Armamentarium

Arastehfar, A. A., Gabaldón, T., Garcia‐Rubio, R., Jenks, J. D., Hoenigl, M., Salzer, H. J. F., İlkit, M., Lass‐Flörl, C., & Perlin, D. S. (2020) · Antibiotics · doi:10.3390/antibiotics9120877 · Cited by 294 · see citing works

The changing epidemiology of fungal infections

Lass‐Flörl, C., & Steixner, S. J. M. (2023) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2023.101215 · Cited by 125 · see citing works

Sterol 14α-Demethylase Ligand-Binding Pocket-Mediated Acquired and Intrinsic Azole Resistance in Fungal Pathogens

Rosam, K., Monk, B. C., & Lackner, M. (2020) · Journal of Fungi · doi:10.3390/jof7010001 · Cited by 78 · see citing works

Antifungal Susceptibility Testing: A Primer for Clinicians

Wiederhold, N. P. (2021) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofab444 · Cited by 80 · see citing works

Resistance to Fluconazole of Candida albicans in Vaginal Isolates: a 10-Year Study in a Clinical Referral Center

Sobel, J. D. (2023) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00181-23 · Cited by 53 · see citing works

Azole Susceptibility Profiles of More than 9,000 Clinical Yeast Isolates Belonging to 40 Common and Rare Species

Desnos-Ollivier, M., Lortholary, O., Bretagne, S., & Dromer, F. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.02615-20 · Cited by 44 · see citing works

Monitoring the Epidemiology and Antifungal Resistance of Yeasts Causing Fungemia in a Tertiary Care Hospital in Madrid, Spain: Any Relevant Changes in the Last 13 Years?

Díaz-García, J., Mesquida, A., Sánchez‐Carrillo, C., Reigadas, E., Muñóz, P., Escribano, P., & Guinea, J. (2021) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01827-20 · Cited by 39 · see citing works

In vitro susceptibility testing for black grain eumycetoma causative agents

van de Sande, W. W. J. (2020) · Transactions of the Royal Society of Tropical Medicine and Hygiene · doi:10.1093/trstmh/traa184 · Cited by 30 · see citing works

Candida and Candidiasis

Pereira, F., & Rammaert, B. (2022) · Elsevier eBooks · doi:10.1016/b978-0-12-818731-9.00230-5 · Cited by 30 · see citing works

Distribution, trends, and antifungal susceptibility of<i>Candida</i>species causing candidemia in Japan, 2010–2019: A retrospective observational study based on national surveillance data

Kajihara, T., Yahara, K., Nagi, M., Kitamura, N., Hirabayashi, A., Hosaka, Y., Abe, M., Miyazaki, Y., & Sugai, M. (2022) · Medical Mycology · doi:10.1093/mmy/myac071 · Cited by 29 · see citing works

A Practical Guide to Antifungal Susceptibility Testing

Otto, W. R., Arendrup, M. C., & Fisher, B. T. (2023) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piad014 · Cited by 25 · see citing works

Challenges in the Management of Invasive Fungal Infections in the Middle East: Expert Opinion to Optimize Management Using a Multidisciplinary Approach

Almaghrabi, R. S., Al-Musawi, T., Albaksami, O., Subhi, A. L., Fakih, R. O. E., & Stone, N. R. H. (2023) · Cureus · doi:10.7759/cureus.44356 · Cited by 19 · see citing works

Improving management and antimicrobial stewardship for bacterial and fungal infections in hospitalized patients with COVID-19

Peghin, M., Vena, A., Graziano, E., Giacobbe, D. R., Tascini, C., & Bassetti, M. (2022) · Therapeutic Advances in Infectious Disease · doi:10.1177/20499361221095732 · Cited by 17 · see citing works

Laboratory and clinical management capacity for invasive fungal infections: the Italian landscape

Vena, A., Bassetti, M., Mezzogori, L., Marchesi, F., Hoenigl, M., Giacobbe, D. R., Corcione, S., Bartoletti, M., Stemler, J., Pagano, L., et al. (2023) · Infection · doi:10.1007/s15010-023-02084-x · Cited by 18 · see citing works

Investigation of Alternative Therapeutic and Biocidal Options to Combat Antifungal-Resistant Zoonotic Fungal Pathogens Isolated from Companion Animals

Meade, E., Savage, M., Slattery, M. A., & Garvey, M. (2021) · Infectious Disease Reports · doi:10.3390/idr13020034 · Cited by 12 · see citing works

Management of Intra-Abdominal Candidiasis in Intensive Care Setting: A Narrative Review

Pais, M. M., Zaragoza, R., Martín‐Loeches, I., Gómez-Bertomeu, F., & Rodríguez, A. H. (2025) · Journal of Fungi · doi:10.3390/jof11050362 · Cited by 11 · see citing works

Azole non-susceptible C. tropicalis and polyclonal spread of C. albicans in Central Vietnam hospitals

Ngo, T. M. C., Santona, A., Fiamma, M., Nu, P. A. T., Thao, T. B., Cappuccinelli, P., & Paglietti, B. (2023) · The Journal of Infection in Developing Countries · doi:10.3855/jidc.17574 · Cited by 10 · see citing works

Recent concepts in fungal involvement in skin and soft tissue infections

Peghin, M., & Ruíz-Camps, I. (2021) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000806 · Cited by 10 · see citing works

Chelation of Mitochondrial Iron as an Antiparasitic Strategy

Arbon, D., Mach, J., Čadková, A., Šipková, A., Štursa, J., Klanicová, K., Machado, M., Ganter, M., Levytska, V. A., Sojka, D., et al. (2024) · ACS Infectious Diseases · doi:10.1021/acsinfecdis.3c00529 · Cited by 9 · see citing works

Advances in transdermal delivery systems for Antifungals: Current approaches and future perspectives

Hamed, R., Alkilani, A. Z., Al-Adhami, Y., Musleh, B., & Aburayya, R. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107776 · Cited by 6 · see citing works

Adequate duration of therapy in severe fungal infections

Bassetti, M., Giacobbe, D. R., Berruti, M., Puente, F. D., & Vena, A. (2020) · Current Opinion in Critical Care · doi:10.1097/mcc.0000000000000758 · Cited by 6 · see citing works

Trends in Clinico-Epidemiological Profile and Outcomes of Patients with HIV-Associated Cryptococcal Meningitis in Shanghai, China, 2013–2023

Zhao, Z., Song, W., Liu, L., Qi, T., Wang, Z., Tang, Y., Sun, J., Xu, S., Yang, J., Wang, J., et al. (2024) · Viruses · doi:10.3390/v16081333 · Cited by 5 · see citing works

Possible COVID-19-Associated Pulmonary Aspergillosis Due to Aspergillus niger in Greece

Katsiari, M., Mavroidi, A., Palla, E., Zourla, K., Alonistiotis, T., Ntorlis, K., Nikolaou, C., Vrioni, G., & Tsakris, A. (2022) · Antibiotics · doi:10.3390/antibiotics11030300 · Cited by 5 · see citing works

Rapid automated antifungal susceptibility testing system for yeasts based on growth characteristics

Yu, J., Chun, H., Wang, T., Zhang, G., Li, J., Zhang, J., Kang, W., Xu, Y., & Zhao, Y. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1153544 · Cited by 3 · see citing works

Therapeutic role of fluconazole in immunocompetent patients with pulmonary cryptococcosis: A case report

Yu, H., Hua, S., Sha, Q., Tang, T., & Cao, Y. (2025) · IDCases · doi:10.1016/j.idcr.2025.e02188 · Cited by 2 · see citing works

Candida species distribution, antifungal susceptibility and trends causing candidemia: a 10-year observation in eastern China

Cong, P., Wang, B., Qi, H., Zhang, G., & Zhongjun, W. (2026) · PeerJ · doi:10.7717/peerj.20832 · Cited by 2 · see citing works

Antifungal and Immunomodulatory Activities of Brazilian Savannah Solanum lypocarpum Tree-Associated Streptomyces Isolates

Nunes, C. B., Ranjan, K., Rodrigues, F. P., Queiroz, M. D. C. V., Marina, C. L., Muehlmann, L. A., Bocca, A. L., & Poças-Fonseca, M. J. (2025) · Pharmaceuticals · doi:10.3390/ph18081158 · Cited by 3 · see citing works

Evaluation of MMV Pandemic Response Box compounds to identify potent compounds against clinically relevant bacterial and fungal clinical isolates in vitro

Sivasankar, S., Appalaraju, B., Grobusch, M. P., & Jeyaraj, S. (2024) · New Microbes and New Infections · doi:10.1016/j.nmni.2024.101444 · Cited by 1 · see citing works

Echinocandin-resistant Candida albicans: A case report from Japan

Hikida, S., Akiyama, Y., Ishikane, M., Shimazu, H., Nasu, R., Shinohara, T., Nagi, M., Shirai, R., Onakado, M., Nakayama, N., et al. (2025) · Journal of Infection and Chemotherapy · doi:10.1016/j.jiac.2025.102856 · Cited by 1 · see citing works

Novel automated antifungal susceptibility testing system for yeasts based on dual-detection algorithm of turbidimetry and colorimetry

Shen, T., Liu, P., Chen, D., Liu, D., Fang, J., Wang, Q., Xu, Y., Tan, C., & Wang, C. (2024) · Journal of Medical Microbiology · doi:10.1099/jmm.0.001811 · Cited by 1 · see citing works

Ozone Treatment Unveils the Veil of Candida parapsilosis Infection in the Knee Joint: A Case Report and Literature Review

Mu, G., Liu, H., Chen, M., Liu, X., & Ou, C. (2020) · Mycopathologia · doi:10.1007/s11046-020-00447-8 · Cited by 1 · see citing works

Antifungal susceptibility testing, reporting and antifungal resistance: current status

Sığ, A. K. (2023) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2023.97957 · Cited by 1 · see citing works

Aspergillus-Human Interactions: From the Environment to Clinical Significance

Thammahong, A. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.98509

TBHEB 2023-1 Vol 80 Full Printed Journal

ERCÖMERT, U. (2023) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2023.78545

CanDRes: Exploring the Mutation Landscape of Candida and its Role in Antifungal Resistance

Kumar, C., Arshi, A., Yadav, A., Chavan, P., & Idicula‐Thomas, S. (2025) · Infection · doi:10.1007/s15010-025-02686-7

Nanoparticles for Fungal Infection Treatment in Animals

Lamba, J. K., Nile, A. S., & Panwar, A. (2026) · Smart nanomaterials technology · doi:10.1007/978-981-95-4542-1_18

The 2025 guidance on the surveillance and control of Candida infections: Recommendations from the China invasive fungal surveillance net (CHIF-NET) study group

Xiao, M., Zhang, L., Wang, H., Fan, X., Zhou, M., Lin, J., Zhang, L., Xia, J., Zong, Z., Sun, W., et al. (2026) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2026.03.003

Clinical strains of Cryptococcus neoformans VNI non-wild type for azoles from Maceió, Alagoas, Brazil

OLIVEIRA, A. D. B. R. D., Fonseca, D. L. D. H., Silva, D. M. W., & Maranhão, F. C. D. A. (2026) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202620251002

Invasive Pulmonary Aspergillosis Mimicking Pseudomonas aeruginosa Pneumonia in Immunocompromised Patients: Radiologic Differentiation

Choi, Y., Ahn, Y., Yoon, C., Jang, H. D., Kim, M. Y., & Kim, S. (2026) · Journal of Korean Medical Science · doi:10.3346/jkms.2026.41.e241

Activity of esomeprazole and fluconazole against Aspergillus fumigatus and Candida albicans: An in vitro study

Jose, S. T. (2026) · doi:10.68050/jams.2026.486

Clinical utility of in vitro antifungal susceptibility testing.

Espinel‐Ingroff, A. (2000) · PubMed · Cited by 30 · see citing works

Role and Interpretation of Antifungal Susceptibility Testing for the Management of Invasive Fungal Infections

Lamoth, F., Lewis, R. E., & Kontoyiannis, D. P. (2020) · Journal of Fungi · doi:10.3390/jof7010017 · Cited by 68 · see citing works

Antifungal drug resistance in molds: Clinical and microbiological factors

Alcázar‐Fuoli, L., Rodrı́guez-Tudela, J. L., & Mellado, E. (2008) · Current Fungal Infection Reports · doi:10.1007/s12281-008-0006-2 · Cited by 10 · see citing works

Analysis of Susceptibility and Drug Resistance of Antifungal Agents in Aspergillosis and Mucormycosis Patients: A Systematic Review

Song, Y., Verweij, P. E., Buil, J. B., de Hoog, S., Liu, J., Guo, J., Liu, W., & Li, R. (2025) · Mycoses · doi:10.1111/myc.70118 · Cited by 1 · see citing works

Antifungal Susceptibility Testing of Candida and Cryptococcus Species and Mechanisms of Resistance: Implications for Clinical Laboratories

Halliday, C. L., Slavin, M. A., & Chen, S. C.-A. (2017) · Current Fungal Infection Reports · doi:10.1007/s12281-017-0282-9 · Cited by 3 · see citing works